Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings

Case Reports in Neurology
Peter FlacheneckerCarlos Vila

Abstract

Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune demyelinating disease of the central nervous system. Patients exhibit heterogeneous patterns of disabling symptoms, including spasticity. In the majority of patients with MS spasticity, it and its associated symptoms contribute to disability, interfere with performance of everyday activities, and impair quality of life. Even under treatment with oral antispasticity drugs, about a third of patients continue to experience spasticity of moderate to severe intensity, underscoring the need for additional treatment options. The efficacy of tetrahydrocannabinol:cannabidiol (THC:CBD) oromucosal spray as add-on therapy in patients with refractory MS spasticity has been demonstrated in clinical trials and observational studies. To gain insight into patients' response to treatment at the individual level, in-depth changes from baseline in various clinical scales and video-assessed parameters were evaluated in patients with resistant MS spasticity before and after 1 month of treatment with THC:CBD oromucosal spray. All 6 patients showed ≥20% improvement in the spasticity Numerical Rating Scale (i.e., were initial responders to treatment), but displayed individual v...Continue Reading

References

Feb 1, 1987·Physical Therapy·R W Bohannon, M B Smith
Jun 4, 1999·Brain : a Journal of Neurology·G R CutterE Willoughby
Mar 3, 2006·The New England Journal of Medicine·Elliot M FrohmanCedric S Raine
Mar 3, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A NovotnaUNKNOWN Sativex Spasticity Study Group
Jan 10, 2013·The International Journal of Neuroscience·C Oreja-GuevaraC Vila
Jan 24, 2014·International Journal of MS Care·Ilya KisterJoseph Herbert
May 11, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·F PattiUNKNOWN SA.FE. study group
May 22, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Susana Otero-RomeroXavier Montalban

❮ Previous
Next ❯

Citations

Mar 23, 2021·Expert Review of Neurotherapeutics·José María Prieto González, Carlos Vila Silván

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.